PureTech Provides End of Year Report on Key Progress

Author's Avatar
Dec 22, 2022

PureTech+Health+plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today reported on the key progress made across its Wholly Owned Programs1 and Founded Entities2 in 2022.